Translate
About
Mymetics Corp (PINK:MYMX) — investor relations, events, news, and company updates on 6ix.
Latest News
Aug 31 2022
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
Nov 18 2020
Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant
Nov 2 2020
Mymetics Starts Second Preclinical Study for Virosome-based Covid-19 Vaccine
Sep 23 2020
Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine
Jun 11 2020
Mymetics Receives Support for Virosome-based Covid-19 Vaccine Development from European Vaccine Infrastructure Project (Transvac2)
Financials
Revenue
$533 K
Market Cap
$45
EPS
-115.80